Literature DB >> 19725195

Current enzyme replacement therapy for the treatment of lysosomal storage diseases.

Elizabeth R Lim-Melia1, David F Kronn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725195     DOI: 10.3928/00904481-20090723-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  13 in total

1.  Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.

Authors:  Fan Wang; Wensi Song; Giovanna Brancati; Laura Segatori
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

2.  Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.

Authors:  Shunji Tomatsu; Adriana M Montaño; Vu Chi Dung; Amiko Ohashi; Hirotaka Oikawa; Toshihiro Oguma; Tadao Orii; Luis Barrera; William S Sly
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

Review 3.  Emptying the stores: lysosomal diseases and therapeutic strategies.

Authors:  Frances M Platt
Journal:  Nat Rev Drug Discov       Date:  2017-11-17       Impact factor: 84.694

Review 4.  Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.

Authors:  Kenneth J Valenzano; Richie Khanna; Allan C Powe; Robert Boyd; Gary Lee; John J Flanagan; Elfrida R Benjamin
Journal:  Assay Drug Dev Technol       Date:  2011-06       Impact factor: 1.738

5.  Systemic administration of AAV8-α-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression.

Authors:  Jennifer B Nietupski; Gregory D Hurlbut; Robin J Ziegler; Qiuming Chu; Bradley L Hodges; Karen M Ashe; Mark Bree; Seng H Cheng; Richard J Gregory; John Marshall; Ronald K Scheule
Journal:  Mol Ther       Date:  2011-06-28       Impact factor: 11.454

6.  Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns.

Authors:  Ramakrishna S Sista; Allen E Eckhardt; Tong Wang; Carrie Graham; Jeremy L Rouse; Scott M Norton; Vijay Srinivasan; Michael G Pollack; Adviye A Tolun; Deeksha Bali; David S Millington; Vamsee K Pamula
Journal:  Clin Chem       Date:  2011-08-22       Impact factor: 8.327

7.  Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.

Authors:  Ramakrishna S Sista; Tong Wang; Ning Wu; Carrie Graham; Allen Eckhardt; Theodore Winger; Vijay Srinivasan; Deeksha Bali; David S Millington; Vamsee K Pamula
Journal:  Clin Chim Acta       Date:  2013-05-07       Impact factor: 3.786

8.  Rapid assays for Gaucher and Hurler diseases in dried blood spots using digital microfluidics.

Authors:  Ramakrishna S Sista; Tong Wang; Ning Wu; Carrie Graham; Allen Eckhardt; Deeksha Bali; David S Millington; Vamsee K Pamula
Journal:  Mol Genet Metab       Date:  2013-03-24       Impact factor: 4.797

9.  Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.

Authors:  Shunji Tomatsu; William G Mackenzie; Mary C Theroux; Robert W Mason; Mihir M Thacker; Thomas H Shaffer; Adriana M Montaño; Daniel Rowan; William Sly; Carlos J Alméciga-Díaz; Luis A Barrera; Yasutsugu Chinen; Eriko Yasuda; Kristen Ruhnke; Yasuyuki Suzuki; Tadao Orii
Journal:  Res Rep Endocr Disord       Date:  2012-12

Review 10.  Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders.

Authors:  Giancarlo Parenti; Generoso Andria; Kenneth J Valenzano
Journal:  Mol Ther       Date:  2015-04-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.